Your shopping cart is currently empty

SJ-172550 is a small molecule inhibitor of MDMX (EC50: 5 μM).

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 2 mg | $37 | In Stock | In Stock | |
| 5 mg | $59 | In Stock | In Stock | |
| 10 mg | $97 | In Stock | In Stock | |
| 25 mg | $195 | In Stock | In Stock | |
| 50 mg | $372 | In Stock | In Stock | |
| 100 mg | $638 | In Stock | In Stock | |
| 500 mg | $1,330 | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $66 | In Stock | In Stock |
| Description | SJ-172550 is a small molecule inhibitor of MDMX (EC50: 5 μM). |
| Targets&IC50 | MDMX:5 μM |
| In vitro | SJ-172550 interacts with the p53-binding pocket of MDMX, effectively displacing p53 and reversibly binding to MDMX, resulting in the death of retinoblastoma cells with amplified MDMX expression. This compound establishes a covalent, yet reversible, complex with MDMX, which prohibits MDMX from binding to p53. The efficacy of SJ-172550 is enhanced when used in conjunction with the MDM2 inhibitor, nutlin-3a. The stability of the SJ-172550/MDMX complex is dependent on several factors, such as the media's reducing potential and the presence of aggregates. |
| Molecular Weight | 428.87 |
| Formula | C22H21ClN2O5 |
| Cas No. | 431979-47-4 |
| Smiles | CCOc1cc(\C=C2/C(C)=NN(C2=O)c2ccccc2)cc(Cl)c1OCC(=O)OC |
| Relative Density. | 1.27 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 33.33 mg/mL (77.72 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+90% Corn Oil: 2 mg/mL (4.66 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
| |||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.